Literature DB >> 3954467

Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.

P W Thompson, D D Jones, H L Currey.   

Abstract

Cytidine deaminase (CD), a cytoplasmic enzyme, is thought to leak out of damaged cells and can be measured in fluids by a simple biochemical assay. This study has shown that serum CD activity is raised in rheumatoid arthritis (RA) compared with osteoarthritis (OA). Synovial fluid (SF) CD activity was always less than the corresponding serum activity (mean SF/serum ratio = 0.6) in OA but up to 22 times greater than the corresponding serum activity in RA (mean SF/serum ratio = 13.1), suggesting CD production in inflammatory joints. Evidence to support the SF neutrophil as a cell of CD origin is provided by the CD gradient running from cells to SF to synovium. The close correlation between SF CD activity and neutrophil count (r = 0.93) indicates that SF CD activity is an accurate measure of acute synovial inflammation. Weak correlation of serum CD activity with erythrocyte sedimentation rate (ESR) (r = 0.44) and C-reactive protein (CRP) (r = 0.49) implies that CD estimations supply different though related information about rheumatoid disease activity. We suggest that CD released from damaged neutrophils diffuses from all inflamed joints into the blood, so that serum CD activity may provide an integrated measure of joint inflammation more specific than traditional measures such as the ESR.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954467      PMCID: PMC1001807          DOI: 10.1136/ard.45.1.9

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation.

Authors:  I Kushner; J A Somerville
Journal:  Arthritis Rheum       Date:  1971 Sep-Oct

2.  Cytidine deaminase and the development of resistance to arabinosyl cytosine.

Authors:  C D Steuart; P J Burke
Journal:  Nat New Biol       Date:  1971-09-22

3.  Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.

Authors:  G G Chabot; J Bouchard; R L Momparler
Journal:  Biochem Pharmacol       Date:  1983-04-01       Impact factor: 5.858

4.  Activity of serum cytidine deaminase during pregnancy.

Authors:  D D Jones; S Bahijri; E L Roberts; G F Williams
Journal:  Br J Obstet Gynaecol       Date:  1982-04

5.  Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint diseases.

Authors:  J W Hollingsworth; E R Siegel; W A Creasey
Journal:  Yale J Biol Med       Date:  1967-04
  5 in total
  18 in total

1.  Increased serum cytidine deaminase activity in gout and articular chondrocalcinosis.

Authors:  J Rovenský; M Stancíkova; K Bosmanský; M Kovalancík
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 2.  The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?

Authors:  Audrey Frances; Pierre Cordelier
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

3.  A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.

Authors:  T L Vischer
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

4.  Serum cytidine deaminase as a laboratory test for acute inflammation in rheumatoid arthritis.

Authors:  I M Chalmers; G T Thomson; P Desjardins
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

5.  Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.

Authors:  P W Thompson; J R Kirwan; D D Jones; H L Currey
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

6.  Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis.

Authors:  P S Helliwell; A Marchesoni; M Peters; R Platt; V Wright
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

7.  Serum lactic dehydrogenase as a marker of joint damage in rheumatoid arthritis.

Authors:  P W Thompson; D D Jones
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

8.  Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.

Authors:  B Månsson; P Geborek; T Saxne; S Björnsson
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

9.  Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.

Authors:  R Cohen; L H Preta; V Joste; E Curis; O Huillard; A Jouinot; C Narjoz; A Thomas-Schoemann; A Bellesoeur; M Tiako Meyo; J Quilichini; D Desaulle; I Nicolis; A Cessot; M Vidal; F Goldwasser; J Alexandre; B Blanchet
Journal:  Br J Clin Pharmacol       Date:  2019-01-30       Impact factor: 4.335

10.  Morphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A McCarthy; J Bernhagen; M J Taylor; A S Hamblin; I James; P W Thompson; J D Perry
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.